Table 1 Racial distribution of ATCC’s breast cell line panel constituents
From: Racial disparities in breast cancer preclinical and clinical models
Panel | N | Cell lines | Race |
|---|---|---|---|
ATCC breast cancer cell panel | 45 | 184B5 | Unspecified |
| Â | Â | AU-565 | Caucasian |
| Â | Â | BT-20 | Caucasian |
| Â | Â | BT-474 | Caucasian |
| Â | Â | BT-483 | Caucasian |
| Â | Â | BT-549 | Caucasian |
| Â | Â | CAMA-1 | Caucasian |
| Â | Â | DU4475 | Caucasian |
| Â | Â | HCC38 | Caucasian |
| Â | Â | HCC70 | African |
| Â | Â | HCC202 | Caucasian |
| Â | Â | HCC1187 | Caucasian |
| Â | Â | HCC1395 | Caucasian |
| Â | Â | HCC1419 | Hispanic |
| Â | Â | HCC1428 | Caucasian |
| Â | Â | HCC1500 | African |
| Â | Â | HCC1569 | African |
| Â | Â | HCC1599 | Caucasian |
| Â | Â | HCC1806 | African |
| Â | Â | HCC1937 | Caucasian |
| Â | Â | HCC1954 | East Indian |
| Â | Â | HCC2157 | African |
| Â | Â | HCC2218 | Caucasian |
| Â | Â | Hs 578Bst | Caucasian |
| Â | Â | Hs 578Â T | Caucasian |
| Â | Â | MCF7 | Caucasian |
| Â | Â | MCF 10A | Caucasian |
| Â | Â | MCF 10F | Unspecified |
| Â | Â | MCF-12A | Caucasian |
| Â | Â | MDA-kb2 | Caucasian |
| Â | Â | MDA-MB-134-VI | Caucasian |
| Â | Â | MDA-MB-157 | African |
| Â | Â | MDA-MB-175-VII | African |
| Â | Â | MDA-MB-231 | Caucasian |
| Â | Â | MDA-MB-361 | Caucasian |
| Â | Â | MDA-MB-415 | Caucasian |
| Â | Â | MDA-MB-436 | Caucasian |
| Â | Â | MDA-MB-453 | Caucasian |
| Â | Â | MDA-MB-468 | African |
| Â | Â | SK-BR-3 | Caucasian |
| Â | Â | T47D | Caucasian |
| Â | Â | UACC-812 | Mixed; Native American |
| Â | Â | UACC-893 | Caucasian |
|  |  | ZR-75–1 | Caucasian |
|  |  | ZR-75–30 | African |
Breast cancer biomarkers cell line panel | 7 | UACC-812 | Mixed; Native American |
| Â | Â | UACC-893 | Caucasian |
| Â | Â | UACC-3199 | Caucasian |
| Â | Â | UACC-3133 | Caucasian |
| Â | Â | UACC-1179 | Unspecified |
| Â | Â | UACC-732 | Caucasian |
| Â | Â | UACC-2087 | Unspecified |
Triple-negative breast cancer panel 1; basal-like morphology | 9 | HCC1599 | Caucasian |
| Â | Â | HCC1937 | Caucasian |
| Â | Â | HCC1143 | Caucasian |
| Â | Â | MDA-MB-468 | African |
| Â | Â | HCC38 | Caucasian |
| Â | Â | HCC70 | African |
| Â | Â | HCC1806 | African |
| Â | Â | HCC1187 | Caucasian |
| Â | Â | DU4475 | Caucasian |
Triple-negative breast cancer panel 2, mesenchymal & luminal morphology | 6 | BT-549 | Caucasian |
| Â | Â | Hs 578Â T | Caucasian |
| Â | Â | MDA-MB-231 | Caucasian |
| Â | Â | MDA-MB-436 | Caucasian |
| Â | Â | MDA-MB-157 | African |
| Â | Â | MDA-MB-453 | Caucasian |
Triple-negative breast cancer panel 3 | 17 | HCC1599 | Caucasian |
| Â | Â | HCC1937 | Caucasian |
| Â | Â | HCC1143 | Caucasian |
| Â | Â | MDA-MB-468 | African |
| Â | Â | HCC38 | Caucasian |
| Â | Â | HCC70 | African |
| Â | Â | HCC1806 | African |
| Â | Â | HCC1187 | Caucasian |
| Â | Â | DU4475 | Caucasian |
| Â | Â | BT-549 | Caucasian |
| Â | Â | Hs 578Â T | Caucasian |
| Â | Â | MDA-MB-231 | Caucasian |
| Â | Â | MDA-MB-436 | Caucasian |
| Â | Â | MDA-MB-157 | African |
| Â | Â | MDA-MB-453 | Caucasian |
| Â | Â | BT-20 | Caucasian |
| Â | Â | HCC1395 | Caucasian |
Breast cancer p53 hotspot mutation cell panel | 8 | MDA-MB-175-VII | African |
| Â | Â | MDA-MB-361 | Caucasian |
| Â | Â | AU565 | Caucasian |
| Â | Â | SK-BR-3 | Caucasian |
| Â | Â | HCC70 | African |
| Â | Â | BT-549 | Caucasian |
| Â | Â | HCC38 | Caucasian |
| Â | Â | MDA-MB-468 | African |